Skip to main content

Charles Gersbach

John W. Strohbehn Distinguished Professor of Biomedical Engineering
Biomedical Engineering
Box 90281, 136 Hudson Hall, Durham, NC 27708
2123 CIEMAS, Durham, NC 27708

Scholarly Works - Book sections


Gene delivery into cells and tissues

Book section · January 1, 2020 There are significant engineering challenges in translating gene and nucleic acid delivery from cell and animal models into the clinic. Off-target effects and inefficient delivery to the proper intracellular compartment of the targeted cells are major obst ... Full text Cite

Genome Editing for Duchenne Muscular Dystrophy

Book section · January 1, 2019 The recent genome editing revolution has been fueled by the discovery and adaptation of highly specific endonucleases including meganucleases, zinc finger nucleases (ZFNs), TALENs, and CRISPR/Cas9. These genome editing technologies permit user-defined geno ... Full text Cite

Genome Editing for Neuromuscular Diseases

Book section · January 1, 2016 Neuromuscular diseases are a diverse range of conditions that include myopathic and neuropathic disorders related to muscular dysfunction. Inherited neuromuscular diseases are the result of a broad spectrum of genetic mutations, including point mutations, ... Full text Cite

Genome Engineering for Therapeutic Applications

Book section · January 1, 2015 Modern genome engineering technologies have made the targeted modification of human genes possible for a multitude of therapeutic applications. This chapter discusses the three main platforms that have been developed for targeting specific DNA sequences: z ... Full text Cite

Engineered Proteins for Controlling Gene Expression

Book section · January 1, 2010 This chapter describes the potential uses of natural transcriptional regulators, enhancement of these regulators through molecular engineering, and the engineering of entirely synthetic transcription factors for targeted gene regulation. HIF-1 is a heterod ... Full text Cite